2000
DOI: 10.1074/jbc.m909620199
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Cloning of Globotriaosylceramide/CD77 Synthase, a Glycosyltransferase That Initiates the Synthesis of Globo Series Glycosphingolipids

Abstract: The expression cloning of a cDNA for globotriaosylceramide (Gb3)/CD77 synthase (␣1,4-galactosyltransferase) was achieved using an anti-Gb3 antibody and mouse L cells as a recipient cell line for the transfection. The isolated cDNA clone designated pVTR1 predicted a type II membrane protein with 19 amino acids of cytoplasmic domain, 26 amino acids of transmembrane region, and a catalytic domain with 308 amino acids. Introduction of the cDNA clone into L cells resulted in the neosynthesis of Gb3/CD77, and the ex… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
120
0

Year Published

2003
2003
2023
2023

Publication Types

Select...
4
2
1

Relationship

1
6

Authors

Journals

citations
Cited by 129 publications
(121 citation statements)
references
References 40 publications
(28 reference statements)
1
120
0
Order By: Relevance
“…There are three sequences in zebra finch and one sequence in chicken, and these sequences were annotated "similar to ␣1,4-galactosyltransferase." The BLAST analysis also revealed human (16,17), mouse (18), and rat (19) ␣4GalT(Gal)s as being homologous proteins, as well as some other predicted proteins from mammals that were annotated similar to ␣1,4-galactosyltransferase. The pigeon ␣4GalT(Gal) also has some homology with the human ␣1,4-N-acetylglucosaminyltransferase (␣1,4-N-acetylglucosaminyltransferase, 36.3% identity; accession number AAD48406) and putative ␣1,4-N-acetylglucosaminyltransferase from chicken (34.4%, accession number XP_426692) and zebra finch (31.5%, accession number XP_002189476).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…There are three sequences in zebra finch and one sequence in chicken, and these sequences were annotated "similar to ␣1,4-galactosyltransferase." The BLAST analysis also revealed human (16,17), mouse (18), and rat (19) ␣4GalT(Gal)s as being homologous proteins, as well as some other predicted proteins from mammals that were annotated similar to ␣1,4-galactosyltransferase. The pigeon ␣4GalT(Gal) also has some homology with the human ␣1,4-N-acetylglucosaminyltransferase (␣1,4-N-acetylglucosaminyltransferase, 36.3% identity; accession number AAD48406) and putative ␣1,4-N-acetylglucosaminyltransferase from chicken (34.4%, accession number XP_426692) and zebra finch (31.5%, accession number XP_002189476).…”
Section: Resultsmentioning
confidence: 99%
“…Because the Gal␣1-4Gal sequence is rarely attached to glycoproteins in mammals, the putative ␣4GalT(Gal) in pigeon is likely to have distinct acceptor substrate specificities from those of mammals. Although mammalian ␣4GalT(Gal)s, also known as Gb3 synthases, have been cloned from human (16,17), mouse (18), and rat (19), they utilize lactosylceramide (Gal␤1-4Glc-Cer) as the preferred acceptor substrate to produce Gb3. Only when the expression level of the enzyme is sufficiently high, human Gb3 synthase can also synthesize P 1 antigen using lacto-N-neotetraosylceramide (Gal␤1-4GlcNAc␤1-3Gal␤1-4Glc-Cer) as a substrate (20).…”
mentioning
confidence: 99%
“…On the other hand, the occurrence of the p phenotype is very rare in all nationalities (18,19), suggesting that the genetic basis of p and P2 phenotypes is not directly linked. Actually, no relevant polymorphic sequences in the coding region of the Gb3/CD77 synthase gene could be detected between P1 and P2 individuals, and no P1 synthase activity could be found in cell lysates transfected with a Gb3/CD77 synthase expression vector (8,9). Consequently, it appears difficult to accept that P1 synthase and Gb3/CD77 synthase are identical.…”
mentioning
confidence: 86%
“…Enzyme Assay-Gb3/CD77 synthase activity was measured as described previously (8). The enzyme activity of ␣1,4Gal-T to generate P1 structure was measured as described previously (26).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation